Literature DB >> 32862401

Neurogenesis After Stroke: A Therapeutic Perspective.

Abir A Rahman1, Narayanappa Amruta1, Emmanuel Pinteaux2, Gregory J Bix3,4.   

Abstract

Stroke is a major cause of death and disability worldwide. Yet therapeutic strategies available to treat stroke are very limited. There is an urgent need to develop novel therapeutics that can effectively facilitate functional recovery. The injury that results from stroke is known to induce neurogenesis in penumbra of the infarct region. There is considerable interest in harnessing this response for therapeutic purposes. This review summarizes what is currently known about stroke-induced neurogenesis and the factors that have been identified to regulate it. Additionally, some key studies in this field have been highlighted and their implications on future of stroke therapy have been discussed. There is a complex interplay between neuroinflammation and neurogenesis that dictates stroke outcome and possibly recovery. This highlights the need for a better understanding of the neuroinflammatory process and how it affects neurogenesis, as well as the need to identify new mechanisms and potential modulators. Neuroinflammatory processes and their impact on post-stroke repair have therefore also been discussed.

Entities:  

Keywords:  Cytokines; Neurogenesis; Neuroinflammation; Stroke; Stroke therapy

Year:  2020        PMID: 32862401      PMCID: PMC7803692          DOI: 10.1007/s12975-020-00841-w

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  146 in total

Review 1.  Acute stroke intervention: a systematic review.

Authors:  Shyam Prabhakaran; Ilana Ruff; Richard A Bernstein
Journal:  JAMA       Date:  2015-04-14       Impact factor: 56.272

2.  DISC1 in Astrocytes Influences Adult Neurogenesis and Hippocampus-Dependent Behaviors in Mice.

Authors:  Chantelle E Terrillion; Bagrat Abazyan; Zhongxi Yang; Joshua Crawford; Alexey V Shevelkin; Yan Jouroukhin; Ki Hyun Yoo; Chang Hoon Cho; Robin Roychaudhuri; Solomon H Snyder; Mi-Hyeon Jang; Mikhail V Pletnikov
Journal:  Neuropsychopharmacology       Date:  2017-06-20       Impact factor: 7.853

Review 3.  Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Konark Malhotra; Jason J Chang; Arjun Khunger; David Blacker; Jeffrey A Switzer; Nitin Goyal; Adrian V Hernandez; Vinay Pasupuleti; Andrei V Alexandrov; Georgios Tsivgoulis
Journal:  J Neurol       Date:  2018-06-14       Impact factor: 4.849

4.  Stroke-induced neurogenesis in aged brain.

Authors:  Vladimer Darsalia; Ursula Heldmann; Olle Lindvall; Zaal Kokaia
Journal:  Stroke       Date:  2005-07-07       Impact factor: 7.914

5.  Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.

Authors:  Isabel Bravo-Ferrer; María I Cuartero; Juan G Zarruk; Jesús M Pradillo; Olivia Hurtado; Víctor G Romera; Javier Díaz-Alonso; Juan M García-Segura; Manuel Guzmán; Ignacio Lizasoain; Ismael Galve-Roperh; María A Moro
Journal:  Stroke       Date:  2016-11-29       Impact factor: 7.914

6.  Role of the epigenetic factor Sirt7 in neuroinflammation and neurogenesis.

Authors:  Nicolas Burg; Stefan Bittner; Erik Ellwardt
Journal:  Neurosci Res       Date:  2017-09-20       Impact factor: 3.304

7.  Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior.

Authors:  Yuyan Cheng; Marta Pardo; Rubia de Souza Armini; Ana Martinez; Hadley Mouhsine; Jean-Francois Zagury; Richard S Jope; Eleonore Beurel
Journal:  Brain Behav Immun       Date:  2016-01-06       Impact factor: 7.217

8.  Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats.

Authors:  Lei Wang; Zhenggang Zhang; Ying Wang; Ruilan Zhang; Michael Chopp
Journal:  Stroke       Date:  2004-06-03       Impact factor: 7.914

Review 9.  Neuroinflammation: friend and foe for ischemic stroke.

Authors:  Richard L Jayaraj; Sheikh Azimullah; Rami Beiram; Fakhreya Y Jalal; Gary A Rosenberg
Journal:  J Neuroinflammation       Date:  2019-07-10       Impact factor: 8.322

Review 10.  Reperfusion therapies for acute ischemic stroke: an update.

Authors:  Laura Dorado; Mònica Millán; Antoni Dávalos
Journal:  Curr Cardiol Rev       Date:  2014-11
View more
  21 in total

1.  The Unconventional Growth Factors Cerebral Dopamine Neurotrophic Factor and Mesencephalic Astrocyte-Derived Neurotrophic Factor Promote Post-ischemic Neurological Recovery, Perilesional Brain Remodeling, and Lesion-Remote Axonal Plasticity.

Authors:  Ahmet Burak Caglayan; Mustafa Caglar Beker; Elif Sertel Evren; Berrak Caglayan; Ülkan Kilic; Nilay Ates; Aysun Caglayan; Muhammed Furkan Dasdelen; Thorsten Roland Doeppner; Mart Saarma; Dirk Matthias Hermann; Ertugrul Kilic
Journal:  Transl Stroke Res       Date:  2022-05-18       Impact factor: 6.829

Review 2.  Endogenous Neural Stem Cell-induced Neurogenesis after Ischemic Stroke: Processes for Brain Repair and Perspectives.

Authors:  Hailiang Tang; Yao Li; Weijun Tang; Jianhong Zhu; Graham C Parker; John H Zhang
Journal:  Transl Stroke Res       Date:  2022-09-03       Impact factor: 6.800

3.  Disruption of Sonic Hedgehog Signaling Accelerates Age-Related Neurogenesis Decline and Abolishes Stroke-Induced Neurogenesis and Leads to Increased Anxiety Behavior in Stroke Mice.

Authors:  Jiapeng Wang; Kierra Ware; Alicia Bedolla; Emily Allgire; Flavia Correa Turcato; Maxwell Weed; Renu Sah; Yu Luo
Journal:  Transl Stroke Res       Date:  2022-02-11       Impact factor: 6.800

4.  Glutamate, Glutamine, GABA and Oxidative Products in the Pons Following Cortical Injury and Their Role in Motor Functional Recovery.

Authors:  Laura E Ramos-Languren; Alberto Avila-Luna; Gabriela García-Díaz; Roberto Rodríguez-Labrada; Yaimee Vázquez-Mojena; Carmen Parra-Cid; Sergio Montes; Antonio Bueno-Nava; Rigoberto González-Piña
Journal:  Neurochem Res       Date:  2021-08-13       Impact factor: 3.996

Review 5.  Roles of Fibroblast Growth Factors and Their Therapeutic Potential in Treatment of Ischemic Stroke.

Authors:  Confidence Dordoe; Keyang Chen; Wenting Huang; Jun Chen; Jian Hu; Xue Wang; Li Lin
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 6.  Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies.

Authors:  Anamaria Jurcau; Aurel Simion
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 7.  Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application.

Authors:  Lakshmy Vasan; Eunjee Park; Luke Ajay David; Taylor Fleming; Carol Schuurmans
Journal:  Front Cell Dev Biol       Date:  2021-07-05

Review 8.  Delayed Recanalization-How Late Is Not Too Late?

Authors:  Ruiqing Kang; Marcin Gamdzyk; Hong Tang; Yujie Luo; Cameron Lenahan; John H Zhang
Journal:  Transl Stroke Res       Date:  2020-11-20       Impact factor: 6.800

9.  BMS-986020, a Specific LPA1 Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice.

Authors:  Bhakta Prasad Gaire; Arjun Sapkota; Ji Woong Choi
Journal:  Antioxidants (Basel)       Date:  2020-11-08

Review 10.  Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke.

Authors:  Reed Berlet; Stefan Anthony; Beverly Brooks; Zhen-Jie Wang; Nadia Sadanandan; Alex Shear; Blaise Cozene; Bella Gonzales-Portillo; Blake Parsons; Felipe Esparza Salazar; Alma R Lezama Toledo; Germán Rivera Monroy; Joaquín Vega Gonzales-Portillo; Cesario V Borlongan
Journal:  Biomolecules       Date:  2021-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.